Trial Profile
A pilot study to evaluate the utility of thermography in assessing response to Golimumab treatment in Psoriatic Arthritis (Go-Thermal)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms Go-Thermal
- 20 Mar 2019 Status changed from recruiting to discontinued.
- 30 Aug 2016 Status changed from not yet recruiting to recruiting.
- 07 Jul 2016 Planned initiation date changed from 15 Jun 2016 to 20 Sep 2016.